D. Williams Parsons

38.2k citations

92 papers · 10.2k indexed · 4 hit papers · h-index 31

Molecular Biology top 1%
Genetics top 0.05%
Cancer Research top 0.2%
Oncology top 1%
Pulmonary and Respiratory Medicine top 2%

Co-authors: Victor E. Velculescu Bert Vogelstein Kenneth W. Kinzler Hai Yan Siân Jones Darell D. Bigner Gregory J. Riggins Genglin Jin
Topics: Cancer Genomics and Diagnostics (21 papers)Neuroblastoma Research and Treatments (18 papers)Genomics and Rare Diseases (16 papers)
Cited by: Genetics Cancer Research Molecular Biology
Journals: Nature Science New England Journal of Medicine
Partner nations: United States Canada United Kingdom

In The Last Decade

D. Williams Parsons

87 papers receiving 10.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IDH1andIDH2Mutations in Gliomas

2009 4.2k citations Hai Yan, D. Williams Parsons et al. profile →
Molecular subgroups of medulloblastoma: the current consensus

2011 1.2k citations Yoon-Jae Cho, D. Williams Parsons et al. profile →
Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene

2009 565 citations Siân Jones, D. Williams Parsons et al. Science profile →
Epitope Landscape in Breast and Colorectal Cancer

2008 318 citations D. Williams Parsons, Victor E. Velculescu et al. profile →

Peers

Countries citing papers authored by D. Williams Parsons

Since Specialization

Citations

This map shows the geographic impact of D. Williams Parsons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Williams Parsons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Williams Parsons more than expected).

Fields of papers citing papers by D. Williams Parsons

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Williams Parsons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Williams Parsons. The network helps show where D. Williams Parsons may publish in the future.

Co-authorship network of co-authors of D. Williams Parsons

This figure shows the co-authorship network connecting the top 25 collaborators of D. Williams Parsons. A scholar is included among the top collaborators of D. Williams Parsons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Williams Parsons. D. Williams Parsons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Improving alcohol-related care in small-medium primary care practices: An evaluation of an adaptation of the SPARC trial intervention for small-medium sized practices 2025 ·Journal of Substance Use and Addiction Treatment ·Leah Hamilton,Gwen T. Lapham,(unknown),(unknown),(unknown),D. Williams Parsons,(unknown),(unknown),Amy K. Lee,(unknown),Katharine A. Bradley	0
2	Combined bioinformatic and splicing analysis of likely benign intronic and synonymous variants reveals evidence for pathogenicity 2024 ·SHILAP Revista de lepidopterología ·(unknown),(unknown),Surya P. Rednam,Kelly Vallance,D. Williams Parsons,Angshumoy Roy,Gregory M. Cooper,Sharon E. Plon	1
3	Precision Medicine for Childhood Cancer: Current Limitations and Future Perspectives 2024 ·JCO Precision Oncology ·Martin G. McCabe,Birgit Geoerger,Louis Chesler,Darren Hargrave,D. Williams Parsons,Cornelis M. van Tilburg,Gudrun Schleiermacher,John A. Hickman,Sally L. George	4
4	Families' experiences accessing care after genomic sequencing in the pediatric cancer context: “It's just been a big juggle” 2024 ·Journal of Genetic Counseling ·(unknown),Amanda M. Gutierrez,Jill O. Robinson,(unknown),(unknown),Mary A. Majumder,Juan Carlos Bernini,Jonathan Gill,Timothy Griffin,Gail E. Tomlinson,Kelly Vallance,Amy L. McGuire,D. Williams Parsons,Sharon E. Plon,Sarah Scollon	1
5	Views of Adolescents and Young Adults with Cancer and Their Oncologists Toward Patients' Participation in Genomic Research 2023 ·Journal of Adolescent and Young Adult Oncology ·Amanda M. Gutierrez,Jill O. Robinson,(unknown),(unknown),Mary A. Majumder,Sarah Scollon,(unknown),Rebecca Hsu,Wendy Allen‐Rhoades,D. Williams Parsons,Sharon E. Plon,Amy L. McGuire,Janet Malek	2
6	A Validation Framework for Somatic Copy Number Detection in Targeted Sequencing Panels 2022 ·Journal of Molecular Diagnostics ·Raghu Chandramohan,Jacquelyn Reuther,(unknown),Horatiu Voicu,Karla Alvarez,Sharon E. Plon,Dolores López‐Terrada,Kevin E. Fisher,D. Williams Parsons,Angshumoy Roy	4
7	Distinct somatic DICER1 hotspot mutations in three metachronous ovarian Sertoli-Leydig cell tumors in a patient with DICER1 syndrome 2022 ·Cancer Genetics ·(unknown),(unknown),Sarah Scollon,(unknown),Jacquelyn Reuther,(unknown),Ninad Patil,(unknown),Hongzheng Dai,Donna M. Muzny,Richard A. Gibbs,Jennifer L. Bercaw‐Pratt,(unknown),Nino Rainusso,Kevin E. Fisher,Frank Y. Lin,Sharon E. Plon,D. Williams Parsons,Angshumoy Roy	0
8	Durable Response to Larotrectinib in a Child With Histologic Diagnosis of Recurrent Disseminated Ependymoma Discovered to Harbor an NTRK2 Fusion: The Impact of Integrated Genomic Profiling 2021 ·JCO Precision Oncology ·(unknown),Jacquelyn Reuther,Kelsey C. Bertrand,Raghu Chandramohan,(unknown),Arnold C. Paulino,Donna M. Muzny,Jianhong Hu,Richard A. Gibbs,Daniel J. Curry,Fatema Malbari,Murali Chintagumpala,Adekunle M. Adesina,Kevin E. Fisher,Stephen C. Mack,Sharon E. Plon,Angshumoy Roy,D. Williams Parsons,Frank Y. Lin	4
9	Integrated DNA and RNA sequencing reveals targetable alterations in metastatic pediatric papillary thyroid carcinoma 2020 ·Pediatric Blood & Cancer ·(unknown),Jacquelyn Reuther,Raghu Chandramohan,(unknown),Faith Hollingsworth,(unknown),Horatiu Voicu,Nipun Kakkar,(unknown),Stephen F. Sarabia,Mónica E. López,Daniel C. Chelius,(unknown),Priya Mahajan,Rajkumar Venkatramani,Norma Quintanilla,Dolores López‐Terrada,Angshumoy Roy,D. Williams Parsons	13
10	Novel PDGFRB rearrangement in multifocal infantile myofibromatosis is tumorigenic and sensitive to imatinib 2019 ·Molecular Case Studies ·Mohammed Hassan,Erin Butler,(unknown),Angshumoy Roy,Yanbin Zheng,(unknown),Dinesh Rakheja,(unknown),(unknown),Mark R. Rosenzweig,Rachel Erlich,Siraj M. Ali,Patrick J. Leavey,D. Williams Parsons,Stephen X. Skapek,Theodore W. Laetsch	10
11	Undifferentiated Sarcomas in Children Harbor Clinically Relevant Oncogenic Fusions and Gene Copy-Number Alterations: A Report from the Children's Oncology Group 2018 ·Clinical Cancer Research ·Theodore W. Laetsch,Angshumoy Roy,Lin Xu,Jennifer O. Black,Cheryl M. Coffin,Yueh-Yun Chi,Jing Tian,Sheri L. Spunt,Douglas S. Hawkins,Julia A. Bridge,D. Williams Parsons,Stephen X. Skapek	11
12	Pediatric oncology enters an era of precision medicine 2017 ·Current Problems in Cancer ·Nita L. Seibel,Katherine A. Janeway,Carl E. Allen,Susan Chi,Yoon-Jae Cho,Julia Glade Bender,AeRang Kim,Theodore W. Laetsch,Meredith S. Irwin,Naoko Takebe,James V. Tricoli,D. Williams Parsons	34
13	Integrated tumor and germline whole-exome sequencing identifies mutations in MAPK and PI3K pathway genes in an adolescent with rosette-forming glioneuronal tumor of the fourth ventricle 2016 ·Molecular Case Studies ·Frank Y. Lin,Katie Bergstrom,Richard Person,Abhishek Bavle,Leomar Y. Ballester,Sarah Scollon,(unknown),Andrew Jea,Sherri Birchansky,David A. Wheeler,Stacey L. Berg,Murali Chintagumpala,Adekunle M. Adesina,Christine M. Eng,Angshumoy Roy,Sharon E. Plon,D. Williams Parsons	17
14	Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups 2016 ·Hepatology ·Pavel Sumazin,Yidong Chen,Lisa R. Treviño,Stephen F. Sarabia,Oliver Hampton,Kayuri Patel,Toni‐Ann Mistretta,Barry Zorman,Patrick Thompson,Andras Heczey,Sarah A. Comerford,David A. Wheeler,Murali Chintagumpala,Rebecka L. Meyers,Dinesh Rakheja,Milton J. Finegold,Gail E. Tomlinson,D. Williams Parsons,Dolores López‐Terrada	142
15	Germline Findings in Tumor-Only Sequencing: Points to Consider for Clinicians and Laboratories: Table 1. 2015 ·JNCI Journal of the National Cancer Institute ·Victoria M. Raymond,Stacy W. Gray,Sameek Roychowdhury,Steven Joffe,Arul M. Chinnaiyan,D. Williams Parsons,Sharon E. Plon	72
16	A multidimensional analysis of genes mutated in breast and colorectal cancers 2007 ·Genome Research ·Jimmy Lin,Christine Gan,Xiaosong Zhang,Siân Jones,Tobias Sjöblom,Laura D. Wood,D. Williams Parsons,Nickolas Papadopoulos,Kenneth W. Kinzler,Bert Vogelstein,Giovanni Parmigiani,Victor E. Velculescu	92
17	Mutations in a signalling pathway 2005 ·Nature ·D. Williams Parsons,Tian‐Li Wang,Yardena Samuels,Alberto Bardelli,Jordan M. Cummins,(unknown),Natalie Silliman,Janine Ptak,Steve Szabo,James K. V. Willson,Sanford D. Markowitz,Kenneth W. Kinzler,Bert Vogelstein,Christoph Lengauer,Victor E. Velculescu	443
18	Mutational Analysis of the Tyrosine Phosphatome in Colorectal Cancers 2004 ·Science ·Zhenghe Wang,Dong Shen,D. Williams Parsons,Alberto Bardelli,Jason A. Sager,Steve Szabo,Janine Ptak,Natalie Silliman,Brock A. Peters,Michiel S. van der Heijden,Giovanni Parmigiani,Hai Yan,Tian‐Li Wang,Greg Riggins,Steven M. Powell,James K. V. Willson,Sanford D. Markowitz,Kenneth W. Kinzler,Bert Vogelstein,Victor E. Velculescu	412
19	Intragenic SMN mutations : frequency, distribution, evidence of a founder effect, and modification of SMA phenotype by centromeric copy number / 1999 ·OhioLink ETD Center (Ohio Library and Information Network) ·D. Williams Parsons	1
20	Intragenic telSMN Mutations: Frequency, Distribution, Evidence of a Founder Effect, and Modification of the Spinal Muscular Atrophy Phenotype by cenSMN Copy Number 1998 ·The American Journal of Human Genetics ·D. Williams Parsons,Patricia McAndrew,ST Iannaccone,Jerry R. Mendell,Arthur H.M. Burghes,T. Prior	142

About D. Williams Parsons

D. Williams Parsons is a scholar working on Genetics, Cancer Research and Neurology, having authored 92 papers that have together received 10.2k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (21 papers), Neuroblastoma Research and Treatments (18 papers) and Genomics and Rare Diseases (16 papers). The work is most often cited by research in Genetics (4.7k citations), Cancer Research (3.3k citations) and Molecular Biology (5.3k citations). D. Williams Parsons has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Victor E. Velculescu, Bert Vogelstein, Kenneth W. Kinzler, Hai Yan, Siân Jones, Darell D. Bigner, Gregory J. Riggins, Genglin Jin, Allan H. Friedman and Henry S. Friedman. Their work appears in journals such as Nature, Science and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact